iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a significant growth in short interest in July. As of July 31st, there was short interest totaling 7,895 shares, a growth of 158.5% from the July 15th total of 3,054 shares. Based on an average daily trading volume, of 2,182 shares, the days-to-cover ratio is presently 3.6 days. Currently, 5.3% of the company’s stock are sold short.

iShares Neuroscience and Healthcare ETF Stock Performance

NYSEARCA IBRN opened at $39.10 on Friday. The company has a 50-day simple moving average of $37.46 and a 200-day simple moving average of $34.76. The firm has a market capitalization of $5.87 million, a PE ratio of 15.61 and a beta of 0.75. iShares Neuroscience and Healthcare ETF has a one year low of $24.01 and a one year high of $40.42.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.